Steven A. Kates
Director/Board Member chez American Chemical Society
Profil
Steven A.
Kates is a member of the American Chemical Society, American Peptide Society, and Association of Biomolecular Research Facilities.
He was previously the Vice President of Regulatory Affairs at Dicerna Pharmaceuticals, Inc. from 2019 to 2022 and Vice President of Technology at Arch Therapeutics, Inc. He received his undergraduate degree from Bates College and his doctorate from Brandeis University.
Postes actifs de Steven A. Kates
| Sociétés | Poste | Début |
|---|---|---|
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Director/Board Member | - |
American Peptide Society, Inc.
 American Peptide Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Peptide Society, Inc. operates as scientific and educational organization which provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. The company was founded in 1990 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
| Association of Biomolecular Research Facilities | Corporate Officer/Principal | - |
Anciens postes connus de Steven A. Kates
| Sociétés | Poste | Fin |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | General Counsel | 01/11/2022 |
| ARCH THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Steven A. Kates
| Bates College | Undergraduate Degree |
| Brandeis University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARCH THERAPEUTICS, INC. | Distribution Services |
| Entreprise privées | 4 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
American Peptide Society, Inc.
American Peptide Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Peptide Society, Inc. operates as scientific and educational organization which provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. The company was founded in 1990 and is headquartered in London, the United Kingdom. | Commercial Services |
| Association of Biomolecular Research Facilities |
